This Obscure Cannabis Company Could Rival Canopy Growth (TSX:WEED)

Charlotte’s Web Holdings Inc. (TSX:CWEB) is inching closer to the top of the cannabis industry and posing a serious challenge to Canopy Growth Corp (TSX:WEED)(NYSE:CGC).

| More on:
Marijuana plant and cannabis oil bottles isolated

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The shares of cannabis forerunner Canopy Growth are down 12.87% since the firing of Bruce Linton as company CEO. The board of directors felt it was time to focus on profits rather than growth. Whether the decision was right remains to be seen.

Meanwhile, other weed companies, like Charlotte’s Web (TSX:CWEB), are pressing forward. The obscure weed company wants to gain headway in a market that is projected to be worth billions of dollars globally. It’s hard to imagine Charlotte’s Web rivalling the giant, but one day it could happen.

Anchored on wellness

Charlotte’s Web is known more for hemp products instead of marijuana. The management has set lofty goals in the CBD market where the company holds the industry-leading position. Investors should start taking notice. Charlotte’s Web’s power as a major player is about to be unlocked.

The company’s vertically integrated business model is different from a typical cannabis producer. Charlotte’s Web is not a producer or seller of medicinal or recreational marijuana and other marijuana-derived products. The company produces and distributes hemp-based cannabidiol (CBD) wellness products.

Exploiting the superiority

Charlotte’s Web is taking advantage of the leading market position in the rapidly growing hemp industry. The 2018 U.S. Farm Bill protects the sale of hemp-derived CBD. Since Charlotte’s Web’s brand is already established and trusted, the company has a competitive advantage.

The market forecast of hemp-derived CBD retail sales in the U.S. alone is staggering. The estimated annual sales of US$1.1 billion could rise by as much as 581.82% to US$7.5 billion by 2023.

Charlotte’s Web’s over five years of experience in hemp plant cultivation will be put in good stead. The company-operated farms in Colorado along with the partner farms in Kentucky and Oregon are cultivating a significant volume of hemp. In 2018, 306,818 kg of hemp was produced, a large increase from the only 26,636 kg produced in 2017.

Expanding the distribution channels to gain significant market share in the U.S. is a major initiative. National retail chains, drug stores, and specialty retailers will be added to the 6,000 retail locations. The e-commerce business or direct-to-customer channel via the company website has contributed 55% of sales in the fiscal year 2018.

Strong financial performance

Cannabis companies, including Canopy Growth, are reporting spectacular revenue growth but are incurring huge losses. However, Charlotte’s Web is presenting a dissimilar financial performance. Revenue grew by 62.16% and 73.75% in 2017 and 2018, respectively. Last year, net income grew by 57.97%.

Charlotte’s Web will have the impetus to scale cultivation and production given the positive industry trends. From the cultivation to manufacturing and distribution processes, the company can grow exponentially and maintain a strong performance.

Many will agree with my observation that the cannabis industry is in disarray and has yet to stabilize. If I’m looking to invest in a weed company, I’d go for the one that’s growing revenue at a slower pace but reporting a large profit margin. Canopy Growth should restore order in the house, or Charlotte’s Web could rise to the top.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool owns shares of Charlotte's Web Holdings.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »